Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 1/2015

01-01-2015 | Chronic Daily Headache (SJ Wang, Section Editor)

Risk Factors of Chronic Daily Headache or Chronic Migraine

Authors: Soo-Jin Cho, Min Kyung Chu

Published in: Current Pain and Headache Reports | Issue 1/2015

Login to get access

Abstract

Chronic daily headache (CDH) is a common neurological condition that affects 1–4 % of the general population. Most individuals with CDH originally suffered from episodic headaches, but over time, this developed into CDH. Although the pathophysiology of CDH is not fully understood, recent clinical and epidemiological studies suggest some risk factors that are associated with an increased risk of transformation from episodic headaches. If risk factors can be identified, they could provide a base for aggressive preventive intervention and thus decrease the transformation from episodic headaches to eventual CDH. In this article, we review and summarize the current data on risk factors for CDH.
Literature
1.
Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999;39(3):190–6.PubMedCrossRef
2.
Lu S, Fuh J, Chen W, Juang K, Wang S. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001;21(10):980–6.PubMedCrossRef
3.
Stark RJ, Ravishankar K, Siow HC, Lee KS, Pepperle R, Wang S-J. Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic review. Cephalalgia. 2013;33(4):266–83.PubMedCrossRef
4.
Wang S-J, Fuh J-L, Lu S-R, Liu C-Y, Hsu L-C, Wang P-N, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology. 2000;54(2):314–9.PubMedCrossRef
5.
Prencipe M, Casini A, Ferretti C, Santini M, Pezzella F, Scaldaferri N, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001;70(3):377–81.PubMedCentralPubMedCrossRef
6.
Bekkelund SI, Salvesen R. Prevalence of head trauma in patients with difficult headache: the North Norway Headache Study. Headache. 2003;43(1):59–62.PubMedCrossRef
7.
Manzoni G, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgia. 1995;15(1):37–43.PubMedCrossRef
8.
Mathew NT. Chronic daily headache. Handbook of Headache. 2005:113–38.
9.
10.
Solomon S, Lipton RB, Newman LC. Clinical features of chronic daily headache. Headache. 1992;32(7):325–9.PubMedCrossRef
11.
Von Korff M, Galer BS, Stang P. Chronic use of symptomatic headache medications. Pain. 1995;62(2):179–86.CrossRef
12.
Silberstein SD, Lipton RB. Chronic daily headache, including transformed migraine, chronic tension-type headache, and medication overuse. Wolff’s Headache Head Pain. 2001;7:247–82.
13.
Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches field trial of revised IHS criteria. Neurology. 1996;47(4):871–5.PubMedCrossRef
14.
Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38(7):497–506.PubMedCrossRef
15.
16.
Headache Classification Committee of the International Headache Society. The international classification of headache disorders, (beta version). Cephalalgia. 2013;33(9):629–808.CrossRef
17.
Scher A, Stewart W, Ricci J, Lipton R. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106(1):81–9.PubMedCrossRef
18.
Wiendels NJ, Neven AK, Rosendaal FR, Spinhoven P, Zitman FG, Assendelft WJ, et al. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia. 2006;26(12):1434–42.PubMedCrossRef
19.
Wang S-J, Fuh J-L, Lu S-R, Juang K-D. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology. 2007;68(8):591–6.PubMedCrossRef
20.•
Manack A, Buse D, Serrano D, Turkel C, Lipton R. Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology. 2011;76(8):711–8. A population-based study investigating factors associated with remission from CM to EM.PubMedCrossRef
21.
Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006;46(9):1334–43.PubMedCrossRef
22.
Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32.PubMedCrossRef
23.
Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–15.PubMedCrossRef
24.•
Chen YC, Tang CH, Ng K, Wang SJ. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain. 2012;13(4):311–9. This article showed multiple comorbidities of CM compared to non-migraineurs and other migraine subtypes using Taiwan National Health Insurance Research Database and emphasized the higher risk of depression, anxiety, bipolar, and other medical illness in CM sufferers.
25.
Pakalnis A, Butz C, Splaingard D, Kring D, Fong J. Emotional problems and prevalence of medication overuse in pediatric chronic daily headache. J Child Neurol. 2007;22(12):1356–9.PubMedCrossRef
26.••
Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260(8):1960–9. A comprehensive review article summarized the association between psychiatric comorbidity and CM in comparison with EM, using recent data.PubMedCrossRef
27.
Houle TT, Butschek RA, Turner DP, Smitherman TA, Rains JC, Penzien DB. Stress and sleep duration predict headache severity in chronic headache sufferers. Pain. 2012;153(12):2432–40.PubMedCentralPubMedCrossRef
28.
Radat F, Creac’h C, Swendsen J, Lafittau M, Irachabal S, Dousset V, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005;25(7):519–22.PubMedCrossRef
29.
Breslau N, Davis GC, Schultz LR, Peterson EL. Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache. 1994;34(7):387–93.PubMedCrossRef
30.
Rueda-Sanchez M, Diaz-Martinez LA. Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cephalalgia. 2008;28(3):216–25.PubMedCrossRef
31.
Scher A, Lipton R, Stewart W. Habitual snoring as a risk factor for chronic daily headache. Neurology. 2003;60(8):1366–8.PubMedCrossRef
32.•
Fernandes G, Franco AL, Goncalves DA, Speciali JG, Bigal ME, Camparis CM. Temporomandibular disorders, sleep bruxism, and primary headaches are mutually associated. J Orofac Pain. 2013;27(1):14–20. This article showed the mutual association between painful TMD, sleep bruxism, and CM. TMD or sleep bruxism increased risk of CM. Otherwise diagnosis of CM increased risk of TMD with/without sleep bruxism.PubMed
33.
Barbanti P, Aurilia C, Egeo G, Fofi L, Vanacore N. A case-control study on excessive daytime sleepiness in chronic migraine. Sleep Med. 2013;14(3):278–81.PubMedCrossRef
34.
Stuginski-Barbosa J, Macedo HR, Bigal ME, Speciali JG. Signs of temporomandibular disorders in migraine patients: a prospective, controlled study. Clin J Pain. 2010;26(5):418–21.PubMedCrossRef
35.
Goncalves DA, Camparis CM, Speciali JG, Franco AL, Castanharo SM, Bigal ME. Temporomandibular disorders are differentially associated with headache diagnoses: a controlled study. Clin J Pain. 2011;27(7):611–5.PubMedCrossRef
36.
Bevilaqua-Grossi D, Lipton RB, Napchan U, Grosberg B, Ashina S, Bigal ME. Temporomandibular disorders and cutaneous allodynia are associated in individuals with migraine. Cephalalgia. 2010;30(4):425–32.PubMed
37.
Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67(2):252–7.PubMedCrossRef
38.•
Lu SR, Fuh JL, Wang SJ, Juang KD, Chen SP, Liao YC, et al. Incidence and risk factors of chronic daily headache in young adolescents: a school cohort study. Pediatrics. 2013;132(1):e9–16. The role of obesity on the new onset CDH in young adolescents using a school cohort.PubMedCrossRef
39.
Alessi MC, Lijnen HR, Bastelica D, Juhan-Vague I. Adipose tissue and atherothrombosis. Pathophysiol Haemost Thromb. 2003;33(5–6):290–7.PubMedCrossRef
40.
Zelissen PM, Koppeschaar HP, Lips CJ, Hackeng WH. Calcitonin gene-related peptide in human obesity. Peptides. 1991;12(4):861–3.PubMedCrossRef
41.
Baranowska B, Wolinska-Witort E, Martynska L, Chmielowska M, Baranowska-Bik A. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuroendocrinol Lett. 2005;26(4):293–6.PubMed
42.
Bernecker C, Pailer S, Kieslinger P, Horejsi R, Moller R, Lechner A, et al. GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs. Cephalalgia. 2010;30(11):1366–74.PubMedCrossRef
43.
Winter AC, Berger K, Buring JE, Kurth T. Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia. 2009;29(2):269–78.PubMedCentralPubMedCrossRef
44.
Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med. 1992;327(16):1109–14.PubMedCrossRef
45.
Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache a population-based study. Neurology. 2004;63(11):2022–7.PubMedCrossRef
46.
Hering-Hanit R, Gadoth N. Caffeine-induced headache in children and adolescents. Cephalalgia. 2003;23(5):332–5.PubMedCrossRef
47.•
Bigal ME. The paradoxical effects of analgesics and the development of chronic migraine. Arq Nneuropsiquiatria. 2011;69(3):544–51. A review article summarized the association between CM risk and various abortive medications.CrossRef
48.
De Felice M, Ossipov MH, Wang R, Lai J, Chichorro J, Meng I, et al. Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol. 2010;67(3):325–37.PubMed
49.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population‐based study. Headache. 2008;48(8):1157–68.PubMedCrossRef
50.
Starling AJ, Hoffman-Snyder C, Halker RB, Wellik KE, Vargas BB, Dodick DW, et al. Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic. Neurologist. 2011;17(5):297–9.PubMedCrossRef
51.
Katsarava Z, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M, et al. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology. 2009;73(21):1796–803.PubMedCrossRef
52.
Ashina S, Lyngberg A, Jensen R. Headache characteristics and chronification of migraine and tension-type headache: a population-based study. Cephalalgia. 2010;30(8):943–52.PubMed
53.
Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008;71(22):1821–8.PubMedCrossRef
54.
Manzoni GC, Lombardi LL, Lana S, Maffezzoni M, Camarda C, Torelli P. Detection of possible factors favouring the evolution of migraine without aura into chronic migraine. Neurol Sci. 2012;33 Suppl 1:S165–7.PubMedCrossRef
55.
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004;62(5):788–90.PubMedCrossRef
56.
Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R. Increased pain sensitivity is not a risk factor but a consequence of frequent headache: a population-based follow-up study. Pain. 2008;137(3):623–30.PubMedCrossRef
57.
Louter MA, Bosker JE, van Oosterhout WP, van Zwet EW, Zitman FG, Ferrari MD, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain. 2013;136(Pt 11):3489–96.PubMedCrossRef
58.
Misra UK, Kalita J, Bhoi SK. Allodynia in migraine: clinical observation and role of prophylactic therapy. Clin J Pain. 2013;29(7):577–82.PubMedCrossRef
59.
Bigal M, Ashina S, Burstein R, Reed M, Buse D, Serrano D, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 2008;70(17):1525–33.PubMedCentralPubMedCrossRef
60.
Grande RB, Aaseth K, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of primary chronic headache in a population-based sample of 30- to 44-year-old persons. Neuroepidemiology. 2008;30(2):76–83.PubMedCrossRef
61.
Hagen K, Zwart JA, Vatten L, Stovner L, Bovim G. Prevalence of migraine and non‐migrainous headache—head‐HUNT, a large population‐based study. Cephalalgia. 2000;20(10):900–6.PubMedCrossRef
62.
Lantéri-Minet M, Auray J-P, El Hasnaoui A, Dartigues J-F, Duru G, Henry P, et al. Prevalence and description of chronic daily headache in the general population in France. Pain. 2003;102(1):143–9.PubMedCrossRef
63.
Park JW, Moon HS, Kim JM, Lee KS, Chu MK. Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol. 2014;10(30):236–43.
64.
Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, et al. The prevalence and burden of primary headaches in China: a population‐based door‐to‐door survey. Headache. 2012;52(4):582–91.PubMedCrossRef
65.
Fendrich K, Vennemann M, Pfaffenrath V, Evers S, May A, Berger K, et al. Headache prevalence among adolescents—the German DMKG headache study. Cephalalgia. 2007;27(4):347–54.PubMedCrossRef
66.
Wang S-J, Fuh J-L, Lu S-R. Chronic daily headache in adolescents: an 8-year follow-up study. Neurology. 2009;73(6):416–22.PubMedCrossRef
67.
Queiroz L, Peres M, Kowacs F, Piovesan E, Ciciarelli M, Souza J, et al. Chronic daily headache in Brazil: a nationwide population‐based study. Cephalalgia. 2008;28(12):1264–9.PubMedCrossRef
68.
Hagen K, Vatten L, Stovner L, Zwart JA, Krokstad S, Bovim G. Low socio‐economic status is associated with increased risk of frequent headache: a prospective study of 22 718 adults in Norway. Cephalalgia. 2002;22(8):672–9.PubMedCrossRef
69.
Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME. Frequency of headaches in children is influenced by headache status in the mother. Headache. 2010;50(6):973–80.PubMedCrossRef
70.
Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, et al. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009;49(3):412–8.PubMedCrossRef
71.
Russell M, Østergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension‐type headache. Cephalalgia. 1999;19(4):207–10.PubMedCrossRef
72.•
Shin H-E, Han S-J, Lee K-S, Park J-W. Polymorphism of the glutamate transporter protein EAAT2 and migraine transformation into chronic daily headache. J Clin Neurol. 2011;7(3):143–7. A genetic association study for the migraine transformation to CDH.PubMedCentralPubMedCrossRef
73.
Terrazzino S, Sances G, Balsamo F, Viana M, Monaco F, Bellomo G, et al. Role of 2 common variants of 5HT2A gene in medication overuse headache. Headache. 2010;50(10):1587–96.PubMedCrossRef
74.
Stewart W, Scher A, Lipton R. Stressful life events and risk of chronic daily headache: results from the frequent headache epidemiology study. Cephalalgia. 2001;21:279.
75.
Tietjen G, Brandes J, Digre KB, Baggaley S, Martin V, Recober A, et al. History of childhood maltreatment is associated with comorbid depression in women with migraine. Neurology. 2007;69(10):959–68.PubMedCrossRef
76.
Reynolds DJ, Hovanitz CA. Life event stress and headache frequency revisited. Headache. 2000;40(2):111–8.PubMedCrossRef
77.
De Benedittis G, Lorenzetti A, Fieri A. The role of stressful life events in the onset of chronic primary headache. Pain. 1990;40(1):65–75.PubMedCrossRef
78.
De Benedittis G, Lorenzetti A. The role of stressful life events in the persistence of primary headache: major events vs. daily hassles. Pain. 1992;51(1):35–42.PubMedCrossRef
79.
De Leeuw R, Schmidt JE, Carlson CR. Traumatic stressors and post‐traumatic stress disorder symptoms in headache patients. Headache. 2005;45(10):1365–74.PubMedCrossRef
80.
Scher A, Stewart W, Buse D, Krantz D, Lipton R. Major life changes before and after the onset of chronic daily headache: a population‐based study. Cephalalgia. 2008;28(8):868–76.PubMedCrossRef
81.
Passchier J, Schouten J, Donk J, Romunde L. The association of frequent headaches with personality and life events. Headache. 1991;31(2):116–21.PubMedCrossRef
82.
Juang KD, Wang SJ, Fuh JL, Lu SR, Chen YS. Association between adolescent chronic daily headache and childhood adversity: a community‐based study. Cephalalgia. 2004;24(1):54–9.PubMedCrossRef
83.
Kay D, Kerr T, Lassman L. Brain trauma and the postconcussional syndrome. Lancet. 1971;298(7733):1052–5.CrossRef
84.
Walker WC, Seel RT, Curtiss G, Warden DL. Headache after moderate and severe traumatic brain injury: a longitudinal analysis. Arch Phys Med Rehabil. 2005;86(9):1793–800.PubMedCrossRef
85.
Alves WM, Colohan AR, O’Leary TJ, Rimel RW, Jane JA. Understanding posttraumatic symptoms after minor head injury. J Head Trauma Rehabil. 1986;1(2):1–12.CrossRef
86.
87.
Jensen OK, Nielsen FF. The influence of sex and pre-traumatic headache on the incidence and severity of headache after head injury. Cephalalgia. 1990;10(6):285–93.PubMedCrossRef
88.
89.
Weiss HD, Stern BJ, Goldberg J. Post‐traumatic migraine: chronic migraine precipitated by minor head or neck trauma. Headache. 1991;31(7):451–6.PubMedCrossRef
90.
Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep. 2002;6(6):486–91.
91.
Couch JR, Lipton RB, Stewart WF, Scher AI. Head or neck injury increases the risk of chronic daily headache a population-based study. Neurology. 2007;69(11):1169–77.
Metadata
Title
Risk Factors of Chronic Daily Headache or Chronic Migraine
Authors
Soo-Jin Cho
Min Kyung Chu
Publication date
01-01-2015
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 1/2015
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-014-0465-9

Other articles of this Issue 1/2015

Current Pain and Headache Reports 1/2015 Go to the issue

Chronic Daily Headache (SJ Wang, Section Editor)

Sleep and Chronic Daily Headache

Chronic Daily Headache (SJ Wang, Section Editor)

Animal Models of Chronic Migraine

Chronic Daily Headache (SJ Wang, Section Editor)

Update of Chronic Tension-Type Headache

Neuromodulation (M Gofeld, Section Editor)

Intrathecal Baclofen: Effects on Spasticity, Pain, and Consciousness in Disorders of Consciousness and Locked-in Syndrome